Abstract
Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Current Pharmaceutical Design
Title: ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Volume: 17 Issue: 26
Author(s): Pauline Patak and Dirk M. Hermann
Affiliation:
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Abstract: Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Export Options
About this article
Cite this article as:
Patak Pauline and M. Hermann Dirk, ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke, Current Pharmaceutical Design 2011; 17 (26) . https://dx.doi.org/10.2174/138161211797440195
DOI https://dx.doi.org/10.2174/138161211797440195 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design Forms of Iron Binding in the Cells and the Chemical Features of Chelation Therapy
Mini-Reviews in Medicinal Chemistry Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry Editorial: Recent Advances of Cell and Gene Therapy in Kidney Diseases
Current Gene Therapy Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine The Molecular Basis of Conantokin Antagonism of NMDA Receptor Function
Current Drug Targets Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Flavonols and Flavones – Protecting Against Myocardial Ischemia/ Reperfusion Injury by Targeting Protein Kinases
Current Medicinal Chemistry Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases
Current Drug Targets Propofol Pharmacokinetics in Patients with Obstructive Jaundice
Current Drug Delivery Molecular and Biochemical Changes of the Cardiovascular System due to Smoking Exposure
Current Pharmaceutical Design Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Mitochondrial Therapeutics for Cardioprotection
Current Pharmaceutical Design ACE2 and Diabetic Complications
Current Pharmaceutical Design Modulation of Neutrophil Development and Homeostasis
Current Molecular Medicine